Scholar Rock Holding Corp

NASDAQ:SRRK  
29.86
-1.94 (-6.10%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)963.25M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.8 Million
Adjusted EPS-$0.65
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Scholar Rock Holding Corp. Stock, NASDAQ:SRRK

620 Memorial Drive, 2nd floor, Cambridge, Massachusetts 02139
United States of America
Phone: +1.857.259.3860
Number of Employees: 93

Description

Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The company offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.